Market Entry Switzerland, Germany & DACH
Market Entry DACH for
Medtech & Dental
International Medtech, Pharma and Dental companies entering the DACH or Swiss market – I guide the complete process: from market analysis and distribution setup to subsidiary establishment.
after 12 months
Market Entry DACH
How does a successful market entry into the DACH region work for Medtech companies?
Germany is one of the largest Medtech markets in Europe – and one of the most complex. Regulatory requirements (MDR, CE marking), price sensitivity among clinics and practices, strong regional distribution structures and a competitive environment that accepts no half-measures.
International companies from Asia, the USA or other European markets regularly underestimate this complexity. They fail not because of the product – but because of missing local market knowledge, wrong distribution partners or an organisational structure that does not fit the Swiss, German and Austrian market.
Dietmar Heer has operationally guided several market entries into Germany and Switzerland – from the initial market analysis to a running business. He takes on not just an advisory role, but operational responsibility: as an interim manager who is accountable for results.
The 4 phases of a successful market entry into the DACH region
Phase 1
Market analysis & strategy
Competitive landscape, pricing, target customer segments, regulatory requirements, distribution models. Clear decision basis in 2–4 weeks – not a 100-page report.
Concretely, this means checking whether CE marking under MDR already exists or a conformity assessment via a Notified Body is required, clarifying the risk class and resulting approval timeline, and assessing whether an EU-based Authorised Representative is needed. These questions often determine the timeline more than the market work itself.
Phase 2
Identifying & contracting distribution partners
Qualified distributors for Medtech, Dental or Pharma across DACH – from a network built over decades. Negotiation and contract structuring included.
This includes clarifying exclusivity and territory protection, realistic sales targets as a contractual basis, provisions on inventory and product liability, and an exit clause should the partnership fail to reach the expected market penetration. A good distribution agreement protects both sides – not just the manufacturer.
Phase 3
Building the organisational structure
GmbH formation, location selection, first employees, processes and IT infrastructure. Full operational support – not just advisory.
Phase 4
Market development & first revenues
Sales development, customer acquisition, marketing measures. First deals as proof the model works – before scaling.
This phase reveals whether the pricing model and messaging fit the DACH audience. Typical levers: winning reference customers for trade fairs and KOL networks, adapting the sales process to hospital or practice procurement structures, and staying closely involved with the distribution partner in the first months rather than fully delegating.
Case Study
For a Chinese manufacturer of large-scale medical equipment, Dietmar Heer led market analysis and the setup of a German subsidiary – from strategy to operational execution. Result: EUR 400,000 revenue after 12 months.
Planning a market entry into the DACH region or Switzerland?
First consultation free of charge. I respond within 24 hours.
Get in touchContact
Enquiry: Market Entry DACH
FAQ